{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:06:29Z","timestamp":1761743189989},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ygyno.2008.12.033","type":"journal-article","created":{"date-parts":[[2009,3,2]],"date-time":"2009-03-02T09:07:44Z","timestamp":1235984864000},"page":"195-199","source":"Crossref","is-referenced-by-count":11,"title":["A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer"],"prefix":"10.1016","volume":"113","author":[{"given":"Edwin A.","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron H.","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Matt","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith P.","family":"Crisp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas C.","family":"Lambrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Joseph A.","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2008.12.033_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2008.12.033_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.ygyno.2008.12.033_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1525-1438.2003.13378.x","article-title":"Chemoradiation: a new approach for the treatment of cervical cancer","volume":"13","author":"Loizzi","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"Suppl 10","key":"10.1016\/j.ygyno.2008.12.033_bib4","doi-asserted-by":"crossref","first-page":"x224","DOI":"10.1093\/annonc\/mdl264","article-title":"Concurrent chemoradiation for locally advanced carcinoma of the cervix: where are we in 2006?","volume":"17","author":"Rose","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.033_bib5","first-page":"CD002225","article-title":"Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix","volume":"3","author":"Green","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2008.12.033_bib6","unstructured":"Nieves-Neira W, Lambrou N, Davis K, Ghurani G, Mendez L, Mirhashemi R, Wolfson A, Penalver M. Major complications associated with cisplatin radiosensitization for the treatment of cervical carcinoma. Poster presentation at the Thirty-Third Annual Meeting of the Society of Gynecologic Oncologists, March 16\u201320, 2002. Abstract 147."},{"issue":"4","key":"10.1016\/j.ygyno.2008.12.033_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","article-title":"Studies with RP 56976 (Taxotere): a semisynthetic analogue of taxol","volume":"83","author":"Ringel","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2008.12.033_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/jm00107a017","article-title":"Relationships between the structure of taxol analogues and their antimitotic activity","volume":"34","author":"Gu\u00e9ritte-Voegelein","year":"1991","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ygyno.2008.12.033_bib9","first-page":"1613","article-title":"Differing responses to radiation of murine bone marrow stem cells in relation to the cell cycle","volume":"31","author":"Chaffey","year":"1971","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.12.033_bib10","first-page":"500","article-title":"Radiation sensitizing effects of Taxotere","volume":"33","author":"Choy","year":"1992","journal-title":"Proc. Am. Assoc. Cancer Res."},{"issue":"8","key":"10.1016\/j.ygyno.2008.12.033_bib11","first-page":"1842","article-title":"Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells","volume":"56","author":"Hennequin","year":"1996","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ygyno.2008.12.033_bib12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/bjc.1995.232","article-title":"S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells","volume":"71","author":"Hennequin","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.12.033_bib13","series-title":"Taxotere\u00ae Prescribing Information","year":"2007"},{"issue":"11","key":"10.1016\/j.ygyno.2008.12.033_bib14","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/sj.bjc.6690599","article-title":"Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma","volume":"80","author":"Koukourakis","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2008.12.033_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.1998.16.1.159","article-title":"Phase I study of docetaxel with concomitant thoracic radiation therapy","volume":"16","author":"Mauer","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2008.12.033_bib16","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.3816\/CLC.2000.s.006","article-title":"A phase i trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) trial","volume":"1","author":"Choy","year":"2000","journal-title":"Clin. Lung Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2008.12.033_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00006676-200310000-00003","article-title":"Docetaxel and radiotherapy and pancreatic cancer","volume":"27","author":"Viret","year":"2003","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.ygyno.2008.12.033_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF02966728","article-title":"Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer","volume":"10","author":"Karasawa","year":"2003","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2008.12.033_bib19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.2004.02.001","article-title":"Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate","volume":"22","author":"Kumar","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.12.033_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2005.05.010","article-title":"Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I\/II study with 5 years' follow-up","volume":"50","author":"Brunsvig","year":"2005","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2008.12.033_bib21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/cncr.10873","article-title":"A phase I\/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck","volume":"95","author":"Tishler","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2008.12.033_bib22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ijrobp.2006.02.010","article-title":"Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck","volume":"65","author":"Tishler","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ygyno.2008.12.033_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0360-3016(03)01370-1","article-title":"Radiotherapy with concomitant weekly docetaxel for stages III\/IV oropharynx carcinoma. Results of the 98\u201302 GORTEC Phase II trial","volume":"58","author":"Calais","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ygyno.2008.12.033_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10147-003-0375-z","article-title":"Japan Cooperative Head and Neck Oncology Group (JCHNOG). Phase I\/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck","volume":"9","author":"Fujii","year":"2004","journal-title":"Int. J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.12.033_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jjco\/hyi058","article-title":"Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications","volume":"35","author":"Kodaira","year":"2005","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.12.033_bib26","unstructured":"http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf (current guidelines)"},{"issue":"3","key":"10.1016\/j.ygyno.2008.12.033_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.12.033_bib28","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/sim.856","article-title":"Projecting the standard error of the Kaplan\u2013Meier estimator","volume":"20","author":"Cantor","year":"2001","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2008.12.033_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1008226416896","article-title":"Docetaxel and interstitial pulmonary injury","volume":"8","author":"Merad","year":"1997","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.12.033_bib30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/cncr.10263","article-title":"Severe interstitial pneumonitis associated with docetaxel administration","volume":"94","author":"Read","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2008.12.033_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000081339","article-title":"Acute interstitial pneumopathy associated with docetaxel hypersensitivity","volume":"27","author":"Karacan","year":"2004","journal-title":"Onkologie"},{"issue":"9","key":"10.1016\/j.ygyno.2008.12.033_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1054\/bjoc.2001.2071","article-title":"Life-threatening hypersensitivity pneumonitis induced by docetaxel (Taxotere)","volume":"85","author":"Wang","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2008.12.033_bib33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/030089160609200614","article-title":"Fatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone-refractory prostate cancer","volume":"92","author":"Leimgruber","year":"2006","journal-title":"Tumori"},{"issue":"4","key":"10.1016\/j.ygyno.2008.12.033_bib34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1378\/chest.129.4.1031","article-title":"A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy","volume":"129","author":"Chen","year":"2006","journal-title":"Chest"},{"issue":"16s Pt 1","key":"10.1016\/j.ygyno.2008.12.033_bib35","volume":"23","author":"Kelly","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3 Pt 1","key":"10.1016\/j.ygyno.2008.12.033_bib36","first-page":"814","article-title":"Late urological complications and malignancies after curative radiotherapy for gynecological carcinomas: a retrospective analysis of 10,709 patients","volume":"158","author":"Maier","year":"1997","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.ygyno.2008.12.033_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/0360-3016(95)00118-I","article-title":"Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix","volume":"32","author":"Eifel","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ygyno.2008.12.033_bib38","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB\u2013IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.ygyno.2008.12.033_bib39","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2008.12.033_bib40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000238435","article-title":"Efficacy of the anticancer agent cisplatin in the treatment of human cervical squamous carcinoma xenografted in nude mice","volume":"32","author":"Pillay","year":"1986","journal-title":"Chemotherapy"},{"issue":"15","key":"10.1016\/j.ygyno.2008.12.033_bib41","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study","volume":"22","author":"Moore","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.12.033_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0360-3016(95)02088-8","article-title":"Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines","volume":"34","author":"Britten","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ygyno.2008.12.033_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s002800050020","article-title":"Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer","volume":"45","author":"Gallo","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.12.033_bib44","first-page":"13","article-title":"Neoadjuvant treatment with docetaxel and the effects of irradiation for human ovarian adenocarcinoma and cervical squamous cell carcinoma in vitro","volume":"56","author":"Araki","year":"2002","journal-title":"Acta Med. Okayama"},{"issue":"5","key":"10.1016\/j.ygyno.2008.12.033_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.coc.0000037109.12434.52","article-title":"Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma","volume":"26","author":"Vallejo","year":"2003","journal-title":"Am. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.12.033_bib46","first-page":"173","article-title":"Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: a well-tolerated alternative","volume":"18","author":"Giardina","year":"1997","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.12.033_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00130404-200601000-00011","article-title":"Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer","volume":"12","author":"Allal","year":"2006","journal-title":"Cancer J."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808011141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808011141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T07:18:35Z","timestamp":1589613515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808011141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0090825808011141"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.12.033","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}